Health

Cancer Drug Pulled From the Market Regains FDA Approval

TribeNews
By TribeNews 1 View Add a Comment
0 Min Read
Cancer Drug Pulled From the Market Regains FDA Approval

MedPage Today) — The FDA has once again approved belantamab mafodotin (Blenrep) for multiple myeloma, 3 years after the drug left the market over questions about its efficacy.
A B-cell maturation antigen (BCMA)-targeted drug, belantamab mafodotin…

Leave a Comment
Ads Blocker Image Powered by Code Help Pro

Ads Blocker Detected & This Is Prohibited!!!

We have detected that you are using extensions to block ads and you are also not using our official app. Your Account Have been Flagged and reported, pending de-activation & All your earning will be wiped out. Please turn off the software to continue

You cannot copy content of this app